BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1315 related articles for article (PubMed ID: 24531426)

  • 1. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
    Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
    Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage.
    Pottier V; Pierrot M; Subra JF; Mercat A; Kouatchet A; Parrot A; Augusto JF
    Lupus; 2011 May; 20(6):656-9. PubMed ID: 21335399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C; Kourilovitch MR; Molineros JE; Cardiel MH; Zurita L; Soroka NF; Yagur VY; Doukh N; Cervera R
    Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent diffuse alveolar haemorrhage in a patient with systemic lupus erythematosus: long-term benefit of rituximab.
    Martínez-Martínez MU; Abud-Mendoza C
    Lupus; 2012 Sep; 21(10):1124-7. PubMed ID: 22460294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of systemic lupus erythematosus associated with severe acute pancreatitis].
    Tahara K; Nishiya K; Nishioka T; Yoshida T; Matsubara Y; Hashimoto K
    Ryumachi; 1999 Jun; 39(3):598-603. PubMed ID: 10434757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
    Su GX; Wu FQ; Wang F; Zhou ZX; Huang XL; Lu J
    Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):697-704. PubMed ID: 23158822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide.
    Lehman TJ; Singh C; Ramanathan A; Alperin R; Adams A; Barinstein L; Moorthy N
    Pediatr Rheumatol Online J; 2014 Jan; 12():3. PubMed ID: 24423147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen.
    Ezeonyeji AN; Isenberg DA
    Rheumatology (Oxford); 2012 Mar; 51(3):476-81. PubMed ID: 22096015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
    Pusongchai T; Jungthirapanich J; Khositseth S
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.
    Ale'ed A; Alsonbul A; Al-Mayouf SM
    Rheumatol Int; 2014 Apr; 34(4):529-33. PubMed ID: 24218286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of duodenal malignant lymphoma presenting as acute pancreatitis: systemic lupus erythematosus and immunosuppressive therapy as risk factors.
    Yamada R; Sakuno T; Inoue H; Miura H; Takeuchi T; Shiono Y; Okuse H; Nakamura M; Katsurahara M; Hamada Y; Tanaka K; Horiki N; Takei Y
    Clin J Gastroenterol; 2018 Aug; 11(4):286-290. PubMed ID: 29546569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M; Jones RJ; Brodsky RA
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute pancreatitis: an initial presentation of systemic lupus erythematosus.
    Ghamarchehreh ME; Alishiri G; Bayat N; Khajehpoor H; Nooranipour M
    Turk J Gastroenterol; 2011 Aug; 22(4):433-6. PubMed ID: 21948578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral tuberculosis in a patient with systemic lupus erythematosus following cyclophosphamide treatment: a case report.
    Cooray S; Zhang H; Breen R; Carr-White G; Howard R; Cuadrado M; D'Cruz D; Sanna G
    Lupus; 2018 Apr; 27(4):670-675. PubMed ID: 28764615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisone in lupus nephritis: how much is enough?
    Ruiz-Irastorza G; Danza A; Perales I; Villar I; Garcia M; Delgado S; Khamashta M
    Autoimmun Rev; 2014 Feb; 13(2):206-14. PubMed ID: 24189280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of refractory lupus nephritis with a protocol including rituximab.
    Fra GP; Avanzi GC; Bartoli E
    Lupus; 2003; 12(10):783-7. PubMed ID: 14596429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyspnoea in a young woman with active systemic lupus erythematosus.
    Todd DJ; Costenbader KH
    Lupus; 2009 Aug; 18(9):777-84. PubMed ID: 19578101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.